You are here

abrocitinib

Pfizer posts detailed phase 3 data on its Dupixent rival

Pfizer posts detailed phase 3 data on its Dupixent rival

Fierce Biotech

clinical trials

atopic dermatitis

Flag link:

Pfizer Edges Higher After Positive Trials for Moderate-to-Severe Eczema Drug

Pfizer Edges Higher After Positive Trials for Moderate-to-Severe Eczema Drug

TheStreet.com

clinical trials

Flag link:

Pfizer jumps into the heated PhIII race for new-wave JAK inhibitors — but safety frets loom large

Pfizer jumps into the heated PhIII race for new-wave JAK inhibitors — but safety frets loom large

Endpoints

anti-inflammatories

Flag link: